Literature DB >> 6378977

Fibronectin as an opsonic regulator of monocyte phagocytosis.

A W Simpson, B J Boughton.   

Abstract

Experiments using human monocytes and the yeast Saccharomyces cerevisiae have shown that fibronectin is a major plasma opsonin. Further studies have shown that fibronectin promotes the ingestion as well as the adherence of micro-organisms. These observations are independent of the non-physiological concentrations of heparin used in other assay systems.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378977      PMCID: PMC498810          DOI: 10.1136/jcp.37.7.787

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Electroimmuno assay.

Authors:  C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

2.  Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions.

Authors:  M Vuento; A Vaheri
Journal:  Biochem J       Date:  1979-11-01       Impact factor: 3.857

3.  Ingestion of dyed-opsonised yeasts as a simple way of detecting phagocytes in lymphocyte preparations. Cytophilic binding of immunoglobulins by ingesting cells.

Authors:  A Y Shaala; H S Dhaliwal; S Bishop; N R Ling
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

4.  Opsonic alpha2 surface binding glycoprotein therapy during sepsis.

Authors:  W A Scovill; T M Saba; F A Blumenstock; H Bernard; S R Powers
Journal:  Ann Surg       Date:  1978-10       Impact factor: 12.969

5.  Cryoprecipitate reversal of opsonic alpha2-surface binding glycoprotein deficiency in septic surgical and trauma patients.

Authors:  T M Saba; F A Blumenstock; W A Scovill; H Bernard
Journal:  Science       Date:  1978-08-18       Impact factor: 47.728

6.  A human monocyte system for the assay of plasma opsonins.

Authors:  A W Simpson; B J Boughton
Journal:  J Immunol Methods       Date:  1983-10-28       Impact factor: 2.303

7.  Receptors for cold-insoluble globulin (plasma fibronectin) on human monocytes.

Authors:  M P Bevilacqua; D Amrani; M W Mosesson; C Bianco
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

8.  Fibronectin-mediated uptake of gelatin-coated latex particles by peritoneal macrophages.

Authors:  P W Gudewicz; J Molnar; M Z Lai; D W Beezhold; G E Siefring; R B Credo; L Lorand
Journal:  J Cell Biol       Date:  1980-11       Impact factor: 10.539

  8 in total
  6 in total

1.  Changes in plasma fibronectin during allogeneic bone marrow transplantation.

Authors:  D R Norfolk; M Bowen
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

2.  Fibronectin in polyethylene glycol precipitates: evidence for a role in immune complexes.

Authors:  J S Coppock; D L Scott; S D Carter; T M Moreland; M W Robinson
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

3.  Plasma fibronectin concentrations in patients with HIV infection and visceral leishmaniasis.

Authors:  A Rodríguez-Cuartero; J Nuñez-Carrill; A Salas-Galán; M A Rodríguez-Rodríguez
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

4.  Composition of immune complexes and their relation to plasma fibronectin in chronic myeloproliferative disorders.

Authors:  T P Baglin; A W Simpson; S M Price; B J Boughton
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

5.  Fibronectin and immune complexes in rheumatic diseases.

Authors:  K E Herbert; J S Coppock; A M Griffiths; A Williams; M W Robinson; D L Scott
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

6.  Plasma levels of fibronectin in polymyalgia rheumatica giant cell arteritis.

Authors:  L Puccetti; G Marotta; E Remorini; A Lucchetti; M Zuccotti; G Petrini; U Baicchi; M L Ciompi
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.